Global Gastrointestinal (GI) Endoscopy Devices Market to Reach $49.9 Billion by 2030
The global market for Gastrointestinal (GI) Endoscopy Devices estimated at US$33.6 Billion in the year 2022, is projected to reach a revised size of US$49.9 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2022-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$25.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Capsule Endoscopes segment is readjusted to a revised 5.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $9.1 Billion, While China is Forecast to Grow at 8.6% CAGR
The Gastrointestinal (GI) Endoscopy Devices market in the U.S. is estimated at US$9.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$10.9 Billion by the year 2030 trailing a CAGR of 8.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.8 Billion by the year 2030.Select Competitors (Total 32 Featured) -
- Abbott Nutrition
- Boston Scientific Corporation
- Cardinal Health, Inc.
- ConMed Corporation
- Cook Medical, Inc.
- Erbe Elektromedizin GmbH
- Johnson & Johnson
- Kimberly-Clark Corporation
- Medtronic, Inc.
- Olympus Corporation
- Ricoh Imaging Co., Ltd.
- Stryker Corporation
- Taewoong Medical Co., Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Nutrition
- Boston Scientific Corporation
- Cardinal Health, Inc.
- ConMed Corporation
- Cook Medical, Inc.
- Erbe Elektromedizin GmbH
- Johnson & Johnson
- Kimberly-Clark Corporation
- Medtronic, Inc.
- Olympus Corporation
- Ricoh Imaging Co., Ltd.
- Stryker Corporation
- Taewoong Medical Co., Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 169 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 33.6 Billion |
Forecasted Market Value ( USD | $ 49.9 Billion |
Compound Annual Growth Rate | 5.1% |
Regions Covered | Global |